• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

99.60 +1.11 (+1.13%)
Official Closing Price Updated: 7:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,962,016
Open 98.41
Bid (Size) 99.00 (500)
Ask (Size) 100.30 (200)
Prev. Close 98.49
Today's Range 98.20 - 100.36
52wk Range 81.97 - 134.50
Shares Outstanding 1,750,942,289
Dividend Yield 2.53%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? ↗
October 10, 2026
You'll need to generate $12,000 a year in dividends to average $1k per month from Amgen, Pfizer, J&J, AbbVie, and Bristol Myers Squibb. 
Via The Motley Fool
Topics Intellectual Property
News headline image
History Says Abbott Stock Could More Than Double by 2036. Here’s Why I Just Added It to My Portfolio. ↗
October 10, 2026
Abbott has a low-risk profile with significant upside potential. 
Via The Motley Fool

Performance

52-Week Range 25.9% below 52-week high
99.60
81.9752W Low 134.5052W High
1 Week 1.3% below 1-week high
97.201W Low 100.951W High

Abbott Laboratories (ABT) traded between $81.97 and $134.50 over the past 52 weeks and last traded at $99.60, 25.9% below its 52-week high. Over the past week it ranged between $97.20 and $100.95.

Past 12 Months
-0.5%
-3.6%
+8.1%
-1.1%
-19.8%
-24.9%
1W -$0.50
1M -$3.76
3M +$7.49
6M -$1.09
YTD -$24.59
1Y -$32.97

ABT was -24.9% over the past year, -1.1% over six months, -19.8% year to date, -0.5% in the last week.

12 Months vs Market
ABT
-24.9%
DIA
+13.5%
SPY
+19.2%
QQQ
+27.4%
IWM
+17.3%

Over the past 12 months ABT returned -24.9% versus DIA (Dow) +13.5%, SPY (S&P 500) +19.2%, QQQ (Nasdaq 100) +27.4% and IWM (Russell 2000) +17.3%.

Volume & Liquidity 0.72× 3-mo avg
Today 6,962,016 3-mo avg 9.7M
1W
10.6M
1M
9.3M
3M
9.7M
6M
11.4M
YTD
11.4M
1Y
10.2M

ABT most recently traded 6,962,016 shares against a 3-month average daily volume of 9.7M.

More News

Read More
News headline image
These 3 Dividend Stocks Yield Less Than 10-Year Treasuries Over 5%. Here's Why They Are Better Buys Anyway. ↗
October 01, 2026
Via The Motley Fool
Abbott Laboratories (NYSE:ABT) Clears All Quality Investing Hurdles ↗
August 26, 2026
Via Chartmill
News headline image
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? ↗
October 01, 2026
Via The Motley Fool
News headline image
Want a Portfolio That Pays You $1,000 a Month in Passive Income? This Dividend ETF Could Get You There. ↗
September 24, 2026
Via The Motley Fool
Topics ETFs
News headline image
Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade ↗
September 24, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
3 High-Yielding Dividend Stocks That Are No-Brainer Buys for Retirees and Risk-Averse Investors ↗
September 22, 2026
Via The Motley Fool
News headline image
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth ↗
September 21, 2026
Via The Motley Fool
Topics Product Recall
News headline image
3 Dividend Stocks to Buy and Hold for 10 Years ↗
September 18, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Why Wall Street Is Becoming Even More Bullish About This Dividend King ↗
September 18, 2026
Via The Motley Fool
News headline image
JEPI and JEPQ Yield Way More Than SCHD, but SCHD Could Produce More Passive Income Over the Long Term. Here's Why. ↗
September 17, 2026
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
Is AbbVie the Best Dividend King to Buy in September? ↗
September 16, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
SCHD's Stunning Reversal: Schwab's Flagship Dividend ETF Is Up 29% and Climbing ↗
September 13, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs World Trade
News headline image
If a Stock Market Crash Is Coming, Investors Will Want to Own This Dividend King ↗
September 08, 2026
Via The Motley Fool
News headline image
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It ↗
September 06, 2026
Via MarketBeat
Topics Artificial Intelligence Bonds
News headline image
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King) ↗
September 05, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term Portfolio ↗
September 02, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Just Starting Out With $5,000? 3 Magnificent ETFs to Buy in 2026. ↗
August 31, 2026
Via The Motley Fool
Topics ETFs
News headline image
Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy. ↗
August 26, 2026
Via The Motley Fool
News headline image
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead. ↗
August 24, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? ↗
August 23, 2026
Via The Motley Fool
Topics Lawsuit
News headline image
Recent Report Shows That Rep. Rick Allen Sold Up to $50K Worth of Abbott Laboratories Stock ↗
August 19, 2026
Via Benzinga
News headline image
If You Invest $100 a Month in SCHD, Here's the Passive Income It Could Deliver in 20 Years ↗
August 17, 2026
Via The Motley Fool
Topics ETFs Retirement Stocks
News headline image
Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Stock ↗
August 17, 2026
Via Benzinga

Frequently Asked Questions

Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 99.60
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 10/09/26 07:00 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 174.39B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 174B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap